C. Melvin
- Molecular Biology
- Oncology
- Endocrinology, Diabetes and Metabolism top 10%
- Cancer Research
- Pulmonary and Respiratory Medicine
- Co-authors
- Antonio GualbertoMichaël PollakAlex A. AdjeiPaul HaluskaMadeline RepolletJohann S. de BonoDavid A. ChianeseGerhardt Attard
- Topics
- Growth Hormone and Insulin-like Growth Factors (5 papers)Cancer Treatment and Pharmacology (3 papers)Cancer, Hypoxia, and Metabolism (3 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
C. Melvin
10 papers receiving 320 citations
Peers
Comparison fields: 5 of 41
- Molecular Biology 186
- Oncology 150
- Endocrinology, Diabetes and Metabolism 148
- Cancer Research 139
- Pulmonary and Respiratory Medicine 69
Countries citing papers authored by C. Melvin
This map shows the geographic impact of C. Melvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Melvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Melvin more than expected).
Fields of papers citing papers by C. Melvin
This network shows the impact of papers produced by C. Melvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Melvin. The network helps show where C. Melvin may publish in the future.
Co-authorship network of co-authors of C. Melvin
This figure shows the co-authorship network connecting the top 25 collaborators of C. Melvin. A scholar is included among the top collaborators of C. Melvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Melvin. C. Melvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 4 | |
| 3 | 122 | |
| 4 | Safety and tolerability of the anti-IGF-I receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in patients with advanced solid tumors | 7 |
| 5 | 3 | |
| 6 | 152 | |
| 7 | 32 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 4 |
About C. Melvin
C. Melvin is a scholar working on Endocrinology, Diabetes and Metabolism, Hematology and Cancer Research, having authored 10 papers that have together received 336 indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (5 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (139 citations), Endocrinology, Diabetes and Metabolism (148 citations) and Oncology (150 citations). C. Melvin has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Antonio Gualberto, Michaël Pollak, Alex A. Adjei, Paul Haluska, Madeline Repollet, Johann S. de Bono, David A. Chianese, Gerhardt Attard, Leon W.M.M. Terstappen and Melissa Alsina. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.